Botanical species · safety record

Juniperus oxycedrus

The EFSA Compendium of Botanicals holds 19 constituent measurements and 3 adverse-effect records for Juniperus oxycedrus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Juniperus oxycedrus L.

19Constituent measurements

3Safety records

10Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Juniperus oxycedrus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-alpha-cedrene	Wood	Essential oil	1.4 Percent	GC-MS	Resolve DOI
Alpha-calacorene	Wood	Essential oil	2.8 Percent	GC-MS	Resolve DOI
Alpha-cedrol	Wood	Essential oil	7.3 Percent	GC-MS	Resolve DOI
Myrcene	Cone	Essential oil	21.7 Percent	GC-MS	Resolve DOI
Myrcene	Bark	Essential oil	5.5 Percent	GC-MS	Resolve DOI
Myrcene	Leaves	Essential oil	3.9 Percent	GC-MS	Resolve DOI
Myrcene	Leaves	Essential oil	2.3 Percent	GC-MS	Resolve DOI
Myrcene	Fruit unspecified	Essential oil	≤ 21.9 Percent	GC-MS	Resolve DOI
Myrcene	Fruit unspecified	Essential oil	≥ 14.1 Percent	GC-MS	Resolve DOI
Sennoside b	Leaves	Solvent extraction	—	Chromatographic tests	Resolve DOI
Thujopsene	Wood	Essential oil	11.6 Percent	GC-MS	Resolve DOI
Beta-thujone	Leaves	Essential oil	1.5 Percent	Gaschromatography (GC)	No resolvable identifier
Camphor	Aerial part of plants	Essential oil	4.9 Percent	Gaschromatography (GC)	No resolvable identifier
Diterpenes	Leaves	Essential oil	13.2 Percent	GC-MS	No resolvable identifier
Isocaryophyllene, 5,6-epoxide	Leaves	Essential oil	4.12 Percent	Gaschromatography (GC)	No resolvable identifier
Myrcene	Aerial part of plants	Essential oil	4.9 Percent	Gaschromatography (GC)	No resolvable identifier
Myrcene	Leaves	Essential oil	3.56 Percent	Gaschromatography (GC)	No resolvable identifier
Myrtenol	Leaves	Essential oil	1.03 Percent	Gaschromatography (GC)	No resolvable identifier
Pinocarvone	Leaves	Essential oil	1.01 Percent	Gaschromatography (GC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Urogenital	Live plants	—	Cattle (as animal)	Case report	Resolve DOI
Systemic	Urogenital: kidneys	—	Essential oil (as part-nature)	Human (as organism)	Case report	Resolve DOI
Digestive	Digestive	Leaves	Solvent extraction	—	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Derwich, Elhoussine., Benziane, Zineb., Taouil, Rachid., Senhaji, Omar., Touzani, Mohamed. A comparative study of the chemical composition of the leaves volatile oil of Juniperus phoenicea and Juniperus oxycedrus. Middle east journal of scientific research, 2010, vol. 5, no. 5, p. 416-424.
Achak, Nadia., Romane, Abderrahmane., Alifriqui, Mohamed., Adams, Robert P. Chemical Studies of Leaf Essential Oils of Three Species of Juniperus From Tensift Al Haouz-Marrakech Region (Morocco) . Journal of essential oil research, 2009, vol. 21, no. 4, p. 337-341.
Dahmane, D., Dob, T., Chelghoum, C. Chemical composition and analyses of enantiomers of essential oil obtained by steam distillation of Juniperus oxycedrus L. growing in Algeria. Journal of materials and environmental science, 2015, vol. 6, no. 11, p. 3159-3167.
Hayta, Sukru., Bagci, Eyup. Essential oil constituents of the leaves, bark and cones of Juniperus oxycedrus subsp oxycedrus L. from Turkey . Acta botanica gallica, 2014, vol. 161, no. 2, p. 201-207. DOI
Boti, JB., Bighelli, A., Cavaleiro, C., Saigueiro, L., Casanova, J. Chemical variability of Juniperus oxycedrus ssp oxycedrus berry and leaf oils from Corsica, analysed by combination of GC, GC-MS and C-13-NMR . Flavour and fragrance journal, 2006, vol. 21, no. 2, p. 268-273. DOI
Saab, Antoine M., Guerrini, Alessandra., Sacchetti, Gianni., Maietti, Silvia., Zeino, Ma'en., Arend, Joachim., Gambari, Roberto., Bernardi, Francesco., Efferth, Thomas. Phytochemical Analysis and Cytotoxicity Towards Multidrug-Resistant Leukemia Cells of Essential Oils Derived from Lebanese Medicinal Plants . Planta medica, 2012, vol. 78, no. 18, p. 1927-1931. DOI
Sahin Yaglioglu, A., Eser, F. Screening of some Juniperus extracts for the phenolic compounds and their antiproliferative activities. South african journal of botany, 2017, vol. 113, p. 29-33. DOI
Al-Qura'n, S. Ethnobotanical survey of folk toxic plants in southern part of Jordan. Toxicon, 2005, vol. 46, no. 2, p. 119-129. DOI
Orhan, Nilufer., Hosbas, Sanem., Orhan, Didem Deliorman., Aslan, Mustafa., Ergun, Fatma. Enzyme inhibitory and radical scavenging effects of some antidiabetic plants of Turkey . Iranian journal of basic medical sciences, 2014, vol. 17, no. 6, p. 426-432.
Koruk, ST., Ozyilkan, E., Kaya, P., Colak, D., Donderici, O., Cesaretli, Y. Juniper tar poisoning. Clinical toxicology, 2005, vol. 43, no. 1, p. 47-49. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature